Evidence map›Paper›PMID 41059658›Full record

ArticleBJPsych open2025

Criterion Validity of the Problematic Khat Use Screening Tool (PKUST-17) in Ethiopia.

Awoke Mihretu, Solomon Teferra, Yohannes Gebreegziabhere, Kassahun Habtamu, Abebaw Fekadu

Abstract read
In one paragraph

Article in BJPsych open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Awoke MihretuDepartment of Psychiatry, WHO Collaborating Center for Mental Health Research and Capacity Building, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-5956-114X
Solomon TeferraDepartment of Psychiatry, WHO Collaborating Center for Mental Health Research and Capacity Building, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Yohannes GebreegziabhereDepartment of Nursing, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
Kassahun HabtamuSchool of Psychology, College of Education and Behavioral Studies, Addis Ababa University, Addis Ababa, Ethiopia.
Abebaw FekaduDepartment of Psychiatry, WHO Collaborating Center for Mental Health Research and Capacity Building, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0003-2219-0952

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of amphetamine-type stimulants such as khat has been spreading quickly in eastern parts of Africa, the Arabian region and Asia. However, screening for the provision of early intervention has been inadequate, primarily because of the lack of culturally acceptable and valid screening tools.

aimsTo evaluate the the accuracy of the Problematic Khat Use Screening Tool (PKUST-17) in screening for khat use disorder against the DSM-5 criteria for substance use disorder.

methodA cross-sectional validation study was conducted in Ethiopia from February to December 2018, among a randomly selected sample of 506 individuals. The study subsample comprised 236 participants. We used the DSM-5 criteria for stimulant use disorders as the standard for determining the criterion validity and optimal cut-off score for the PKUST-17, using the receiver operating characteristic (ROC) curve. The DSM-5 criteria for substance use disorders were examined by researchers in a subsample of 232 participants. The PKUST-17 uses a five-point Likert scale (0-4), with total scores ranging from 0 to 68. At the optimal cut-off scores, sensitivity and specificity were determined. In addition, we conducted multivariate logistic regression analysis to evaluate potential convergent validity of the tool.

resultsThe area under the ROC curve showed good performance of the PKUST-17 (0.78, 95% CI 0.70-0.85,

conclusionsWe found that the PKUST-17 is a valid tool for screening for khat use disorder against the DSM-5 criteria for substance use disorder, and identifying high-risk problematic khat users.

Indexed as

Amphetamine-type stimulants (ATS)criterion validityEthiopiakhat use disorderscreening tool

Identifiers

PMID41059658
PMCPMC12529311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.